Epocrates, Inc.  

(Public, NASDAQ:EPOC)   Watch this stock  
Find more results for EPOC
Mar 11 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 6.90 - 11.97
Open     -
Vol / Avg. 0.00/228,735.00
Mkt cap 291.75M
P/E     -
Div/yield     -
EPS -0.30
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -3.90% -3.15%
Operating margin -4.35% -5.32%
EBITD margin - 2.39%
Return on average assets -2.79% -2.56%
Return on average equity -4.78% -14.85%
Employees 360 -
CDP Score - -


Suite 300, 1100 Park Place
United States - Map
+1-650-2271700 (Phone)
+1-650-2272770 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Epocrates, Inc. (Epocrates) is a provider of mobile drug reference tools and electronic health records to healthcare professionals and interactive services to the healthcare industry. As of December 31, 2011, its user network consists of well over one million healthcare professionals, including approximately 340,000, or more than 50% of United States physicians. The Company offers its products on major United States mobile platforms, including Apple iOS, Android and BlackBerry. Epocrates operates in two segments: Subscriptions and Interactive Services, and Electronic Health Records. It uses brand names include DocAlert, Epocrates, Epocrates Honors, Epocrates ID, Epocrates Lab, Epocrates MedTools, Epocrates Rx, Epocrates Rx Pro, Epocrates Dx, Epocrates QuickSurvey, Epocrates QuickRecruit, Epocrates MedInsight, EssentialPoints and MedCafe. In October 2011, it launched a redesign of the drug reference tool to create a new platform that provides healthcare professionals.